Bringing preclinical drug candidates to clinical trials and then to market involves navigating a multi-stage process with significant challenges. Approximately only 1 percent of preclinical candidates will successfully reach the market. The journey typically takes 12 years and costs around $2 billion.
Our advanced AI-powered data analytics platform allows for seamless comparison of preclinical candidates with previously published assets within the same preclinical models. By analyzing these data sets, the technology enables Pharmaceutical companies and investors to correlate preclinical results with clinical trial outcomes, providing crucial insights that enhance decision-making process.
SciDD Pharmaceuticals - AI-powered data analytics for Scientific Due Diligence
#dataanalytics #artificialintelligence #DueDiligence #PharmaIndustry #VentureCapital
Company Details
- Address
- Barcelona, Es
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Pharmaceuticals, Therapeutics, Biopharma, Biotech, Drug Discovery, Drug Development, Preclinical models, Clinical trials, Data Analytics, Artificial Intelligence, Databases.
- HQ
- Barcelona
Scidd Pharmaceuticals Questions
Scidd Pharmaceuticals's website is https://biotech-365.com/preclinical-studies-database/
Scidd Pharmaceuticals's LinkedIn profile is https://es.linkedin.com/company/scidd-pharmaceuticals
Scidd Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Scidd Pharmaceuticals's top competitors are
Leistungszentrum Einzelzelltechnologien Lz-Ezt,
Trialwire™ Patient Enrollment Accelerator Platform,
Matchtx,
Veterinary Venture Capital,
Elevation Strategic Development Uk,
Executive Athlete,
Prucor,
Invesder Capital Partners,
Visconsult,
Oakbloc Technologies Inc.
Scidd Pharmaceuticals's categories are Pharmaceutical Manufacturing
